Scribd Logo
Upload

Welcome to Scribd!

  • 4 views

    Nishant Singh Parihar Male 29 2024 10

    Uploaded by

    Jitender Malik

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Nishant Singh Parihar Male 29 2024 10

    Uploaded by

    Jitender Malik
    4 views5 pages

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    4 views5 pages

    Nishant Singh Parihar Male 29 2024 10

    Uploaded by

    Jitender Malik

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    You are on page 1of 5

    Report for Nishant Singh Pa(29Y/M)

    Tests asked Crp, Hemogram - 6 Part (Dif)

    Test date 22 Oct 2024 Report status Complete Report


    Name : NISHANT SINGH PA(29Y/M) ADDRESS :
    Ref. By : SELF
    ROOM NO 1 GROUND FLOOR U 67/47 U BLOCK
    DLF PHASE 3 SECTOR 24 GALI NU 67 UDYOG
    VIHAR GURGAON

    Report Availability Summary


    Full Report Available
    Note : This is summary page. Please refer to the table below for the details

    Test Report Status

    C-REACTIVE PROTEIN (CRP) Available

    HEMOGRAM - 6 PART (DIFF) Available

    Note : Underlined values are Critical Values, Clinician's attention required. Clinically Tested by : Thyrocare Technologies Ltd.
    NAME : NISHANT SINGH PA(29Y/M) HOME COLLECTION :

    REF. BY : SELF ROOM NO 1 GROUND FLOOR U 67/47 U BLOCK


    DLF PHASE 3 SECTOR 24 GALI NU 67 UDYOG
    TEST ASKED : CRP,HEMOGRAM VIHAR GURGAON

    TEST NAME TECHNOLOGY VALUE UNITS


    C-REACTIVE PROTEIN (CRP) IMMUNOTURBIDIMETRY 26.82 mg/L
    Bio. Ref. Interval. :-

    Acute phase determination : < 5 mg/L

    Clinical Significance:
    It’s a protein present in the sera of acutely ill patients that bound cell wall C-polysaccharide of streptococcus pneumoniae and
    agglutinates the organisms. CRP is one of the strongest acute -phase reactants, with plasma concentrations rising up after
    myocardial infarction, stress, trauma, infection, inflammation, surgery, or neoplastic proliferation.

    Concentrations >5 mg/L suggest the presence of an infection or inflammatory process. Concentrations are generally higher in
    bacterial than viral infection. The increase in peak is proportional to tissue damage. Determination of CRP is clinically useful to
    screen activity of inflammatory diseases such as rheumatoid arthritis; SLE;Leukemia;after surgery;to detect rejection in renal
    allograft recipients;to detect neonatal septicemia and meningitis. However, it is a nonspecific marker and cannot be interpreted
    without other clinical information.

    Reference:
    Tietz Textbook of clinical chemistry and molecular diagnosis fifth edition chapter 21 P538-539

    Please correlate with clinical conditions.


    Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

    Sample Collected on (SCT) : 22 Oct 2024 09:35


    Sample Received on (SRT) : 22 Oct 2024 12:17
    Report Released on (RRT) : 22 Oct 2024 14:26

    Sample Type : SERUM

    Labcode : 2210074133/DG007 Dr Saakshi Mittal MD(Path)

    Barcode : CZ093696 Page : 1 of 3

    Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
    NAME : NISHANT SINGH PA(29Y/M) HOME COLLECTION :
    REF. BY : SELF ROOM NO 1 GROUND FLOOR U 67/47 U BLOCK
    DLF PHASE 3 SECTOR 24 GALI NU 67 UDYOG
    TEST ASKED : CRP,HEMOGRAM
    VIHAR GURGAON

    TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.


    HEMOGLOBIN SLS-Hemoglobin Method 14.6 g/dL 13.0-17.0
    Hematocrit (PCV) CPH Detection 42.7 % 40.0-50.0
    Total RBC HF & EI 4.17 X 10^6/µL 4.5-5.5
    Mean Corpuscular Volume (MCV) Calculated 102.4 fL 83.0-101.0
    Mean Corpuscular Hemoglobin (MCH) Calculated 35 pq 27.0-32.0
    Mean Corp.Hemo. Conc (MCHC) Calculated 34.2 g/dL 31.5-34.5
    Red Cell Distribution Width - SD (RDW-SD) Calculated 46 fL 39-46
    Red Cell Distribution Width (RDW - CV) Calculated 12.1 % 11.6-14
    TOTAL LEUCOCYTE COUNT (WBC) HF & FC 7.13 X 10³ / µL 4.0 - 10.0

    DIFFERENTIAL LEUCOCYTE COUNT


    Neutrophils Percentage Flow Cytometry 59.8 % 40-80
    Lymphocytes Percentage Flow Cytometry 31.6 % 20-40
    Monocytes Percentage Flow Cytometry 4.1 % 2-10
    Eosinophils Percentage Flow Cytometry 3.8 % 1-6
    Basophils Percentage Flow Cytometry 0.4 % 0-2
    Immature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0-0.5
    Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0

    ABSOLUTE LEUCOCYTE COUNT


    Neutrophils - Absolute Count Calculated 4.26 X 10³ / µL 2.0-7.0
    Lymphocytes - Absolute Count Calculated 2.25 X 10³ / µL 1.0-3.0
    Monocytes - Absolute Count Calculated 0.29 X 10³ / µL 0.2 - 1.0
    Basophils - Absolute Count Calculated 0.03 X 10³ / µL 0.02 - 0.1
    Eosinophils - Absolute Count Calculated 0.27 X 10³ / µL 0.02 - 0.5
    Immature Granulocytes (IG) Calculated 0.02 X 10³ / µL 0-0.3
    Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
    PLATELET COUNT HF & EI 304 X 10³ / µL 150-410
    Mean Platelet Volume (MPV) Calculated 10.1 fL 6.5-12
    Platelet Distribution Width (PDW) Calculated 10.9 fL 9.6-15.2
    Platelet to Large Cell Ratio (PLCR) Calculated 24.6 % 19.7-42.4
    Plateletcrit (PCT) Calculated 0.31 % 0.19-0.39

    Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.

    Clinical history is asked for all the relevant abnormalities detected and in absence / failure of receiving of clinical history,
    results are rechecked twice and released. Advised clinical correlation.
    Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
    (Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

    ~~ End of report ~~

    Sample Collected on (SCT) : 22 Oct 2024 09:35


    Sample Received on (SRT) : 22 Oct 2024 12:20
    Report Released on (RRT) : 22 Oct 2024 14:53
    Sample Type : EDTA Whole Blood
    Labcode : 2210074577/DG007 Dr Saakshi Mittal MD(Path)
    Barcode : DA147302 Page : 2 of 3

    Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)
    CONDITIONS OF REPORTING

    v The reported results are for information and interpretation of the referring doctor only.
    v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
    v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
    same patient.
    v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
    v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
    should interpret results.
    v This report is not valid for medico-legal purpose.
    v Docon Technologies Private Limited,Thyrocare Technologies Limited and its employees/representatives do not
    assume any liability,responsibility for any loss or damage that may be incurred by any person as a result of
    presuming the meaning or contents of the report.

    EXPLANATIONS

    v Name - The name is as declared by the client and recorded by the personnel who collected the specimen.
    v Ref.By - The name of the doctor who has recommended testing as declared by the client.
    v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
    v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing the
    barcode (irrespective of the name).
    v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
    v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
    v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
    v Reference Range - Means the range of values in which 95% of the normal population would fall.

    SUGGESTIONS

    v Values out of reference range requires reconfirmation before starting any medical treatment.
    v Retesting is needed if you suspect any quality shortcomings.
    v For suggestions, complaints or feedback, write to us at grievance-office@docon.co.in or call us on 7022000900.

    Page : 3 of 3

    You might also like

    pFad - Phonifier reborn

    Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

    Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


    Alternative Proxies:

    Alternative Proxy

    pFad Proxy

    pFad v3 Proxy

    pFad v4 Proxy